Experimental Hematology
Volume 38, Issue 5 , Pages 403-416, May 2010

Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cells

  • Grant A. Challen

      Affiliations

    • Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, Tex., USA
    • Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Tex., USA
    • Department of Anatomy and Cell Biology, Monash University, Clayton, Victoria, Australia
  • ,
  • Margaret A. Goodell

      Affiliations

    • Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, Tex., USA
    • Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Tex., USA
    • Department of Pediatrics, Baylor College of Medicine, Houston, Tex., USA
    • Corresponding Author InformationOffprint requests to: Margaret A. Goodell, Ph.D., Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030

Received 13 November 2009; received in revised form 25 February 2010; accepted 25 February 2010. published online 04 March 2010.

Objective

RUNX1 (also known as acute myeloid leukemia 1) is an essential regulator of hematopoiesis and has multiple isoforms arising from differential splicing and utilization of two promoters. We hypothesized that the rare Runx1c isoform has a distinct role in hematopoietic stem cells (HSCs).

Materials and Methods

We have characterized the expression pattern of Runx1c in mouse embryos and human embryonic stem cell (hESC)–derived embryoid bodies using in situ hybridization and expression levels in mouse and human HSCs by real-time polymerase chain reaction. We then determined the functional effects of Runx1c using enforced retroviral overexpression in mouse HSCs.

Results

We observed differential expression profiles of RUNX1 isoforms during hematopoietic differentiation of hESCs. The RUNX1a and RUNX1b isoforms were expressed consistently throughout hematopoietic differentiation, whereas the RUNX1c isoform was only expressed at the time of emergence of definitive HSCs. RUNX1c was also expressed in the AGM region of E10.5 to E11.5 mouse embryos, the region where definitive HSCs arise. These observations suggested that the RUNX1c isoform may be important for the specification or function of definitive HSCs. However, using retroviral overexpression to study the effect of RUNX1 isoforms on HSCs in a gain-of-function system, no discernable functional difference could be identified between RUNX1 isoforms in mouse HSCs. Overexpression of both RUNX1b and RUNX1c induced quiescence in mouse HSCs in vitro and in vivo.

Conclusions

Although the divergent expression profiles of Runx1 isoforms during development suggest specific roles for these proteins at different stages of HSC maturation, we could not detect an important functional distinction in adult mouse HSCs using our assay systems.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-472X(10)00076-7

doi:10.1016/j.exphem.2010.02.011

Experimental Hematology
Volume 38, Issue 5 , Pages 403-416, May 2010